Rehman Saba, Rahimi Nader, Dimri Manjari
Boston University Medical Campus, Boston, MA
George Washington University
G protein-coupled receptors (GPCRs) are integral membrane proteins containing an extracellular amino terminus, seven transmembrane α-helical domains, and an intracellular carboxy terminus. GPCRs recognize a wide variety of signals ranging from photons to ions, proteins, neurotransmitters, and hormones. The human genome encodes nearly 800 GPCRs, representing over 3% of human genes. The GPCR superfamily comprises at least five structurally distinct subfamilies: Glutamate, Rhodopsin, Adhesion, Frizzled/Taste2, and Secretin receptor families. About 90% of all GPCRs belong to the rhodopsin family. Impaired ligand concentration, GPCR protein expression, or mutation and signaling are implicated in many pathophysiological conditions, including central nervous system (CNS) disorders, cardiovascular and metabolic diseases, respiratory malfunctions, gastrointestinal disorders, immune diseases, cancer, musculoskeletal pathologies, and eye diseases. Targeting of GPCRs is hence widely utilized for therapeutic intervention; GPCRs correspond to 30% of all identified drug targets and remain major targets for new drug development. Signal transduction through G proteins is the most prominent feature of GPCRs, initiated by a ligand-GPCR interaction at the cell surface level.
G蛋白偶联受体(GPCRs)是整合膜蛋白,包含细胞外氨基末端、七个跨膜α螺旋结构域和细胞内羧基末端。GPCRs识别从光子到离子、蛋白质、神经递质和激素等各种各样的信号。人类基因组编码近800种GPCRs,占人类基因的3%以上。GPCR超家族至少包括五个结构不同的亚家族:谷氨酸、视紫红质、黏附、卷曲/味觉2和分泌素受体家族。所有GPCRs中约90%属于视紫红质家族。配体浓度受损、GPCR蛋白表达、突变和信号传导与许多病理生理状况有关,包括中枢神经系统(CNS)疾病、心血管和代谢疾病、呼吸功能障碍、胃肠道疾病、免疫疾病、癌症、肌肉骨骼疾病和眼部疾病。因此,靶向GPCRs被广泛用于治疗干预;GPCRs占所有已确定药物靶点的30%,仍然是新药开发的主要靶点。通过G蛋白进行信号转导是GPCRs最突出的特征,由细胞表面水平的配体-GPCR相互作用引发。